Picture of Nutex Health logo

NUTX — Nutex Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSuper Stock

Nutex Health Inc expected to post a loss of $1.58 a share - Earnings Preview

Nutex Health Inc NUTX.OQ NUTX.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

The Houston Texas-based  company is expected to report a 145.4% increase in revenue to $186.686 million from $76.08 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Nutex Health Inc is for a loss of $1.58 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Nutex Health Inc is $225.00, about 62.7% above its last closing price of $84.00

This summary was machine generated August 4 at 11:08 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Nutex Health

See all news